Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 4, 2004. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is limited to reporting specific equity transactions and does not contain financial performance data.
Material Changes
The primary material change reported is a transfer of 7,686 Ordinary Shares from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on October 1, 2004, and was reported to the company on October 4, 2004.
Outlook and Risks
The filing contains no guidance, outlook, management commentary, risks, contingencies, or unusual items. It strictly details the mechanics of the share transfer and the status of the GSK Trust as a discretionary trust for employees and former employees.
Key Facts for Investors
- 7,686 Ordinary Shares were transferred from the GSK Trust to employee plan participants.
- Directors Dr J-P Garnier, Dr T Yamada, and Mr J D Coombe hold interests in the GSK Trust shares in the same capacity as other employees.
- No financial performance metrics are disclosed in this specific filing.